The Global Pharmaceutical Contract Development and Manufacturing Market size is expected to grow at an annual average of 7% during 2021-2027. The market growth is mainly driven by factors such as increasing demand for generics, increasing investment in pharmaceutical R&D, and investment in advanced manufacturing technologies by CDMOs. Rising demand for biological therapies, growing interest in specialty pharmaceuticals, growth in the nuclear medicine sector, and advances in cell and gene therapy are expected to provide opportunities for market growth in the future.
A full report of Pharmaceutical Contract Development and Manufacturing Market available at: https://www.orionmarketreports.com/pharmaceutical-contract-development-and-manufacturing-market/58390/
Major Players
• Catalent Inc.
• Recipharm AB
• Jubilant Life Sciences Ltd.
• Patheon Inc.
• Boehringer Ingelheim Group
Pharmaceutical Contract Development and Manufacturing Market- Segmentation
By Service
• Pharmaceutical Manufacturing Services
• Drug Development Services
• Biologics Manufacturing Services
• Biologics API Manufacturing Services
• Biologics FDF Manufacturing Services
By End User
• Big Pharmaceutical Companies
• Small & Medium-Sized Pharmaceutical Companies
• Generic Pharmaceutical Companies
• Other End Users
(This release has been published on Global Market Post. Global Market Post is not responsible for any content included in this release.)
